Evidence map›Paper›PMID 33125394›Full record

ArticlePloS one2020

Class 1 integron-borne cassettes harboring blaCARB-2 gene in multidrug-resistant and virulent Salmonella Typhimurium ST19 strains recovered from clinical human stool samples, United States.

Daniel F M Monte, Fábio P Sellera, Ralf Lopes, Shivaramu Keelara, Mariza Landgraf, Shermalyn Greene, Paula J Fedorka-Cray, Siddhartha Thakur

Erratum issuedAbstract readComparative Study
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Antibiotic Resistance Profile ofMicroorganisms · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Genomic insights ofFrontiers in microbiology · 2022
    Article
  13. Epidemiology ofFrontiers in microbiology · 2022
    Article
  14. Genomic Characterization ofFrontiers in microbiology · 2022
    Article
  15. Article
  16. In Silico Detection of Antimicrobial Resistance Integrons inAntibiotics (Basel, Switzerland) · 2021
    Article
  17. Genomic Investigation ofFrontiers in microbiology · 2021
    Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Daniel F M MonteDepartment of Food and Experimental Nutrition, Food Research Center, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-3787-1988
Fábio P SelleraDepartment of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-4725-0125
Ralf LopesDepartment of Clinical Analyses, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.ORCID 0000-0001-8223-1758
Shivaramu KeelaraDepartment of Population Health and Pathobiology, North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina, United States of America.
Mariza LandgrafDepartment of Food and Experimental Nutrition, Food Research Center, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-9260-8579
Shermalyn GreeneDepartment of Health and Human Services, Molecular Diagnostic and Epidemiology Laboratory Unit at State Laboratory of Public Health, Division of Public Health, Raleigh, North Carolina, United States of America.
Paula J Fedorka-CrayDepartment of Population Health and Pathobiology, North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina, United States of America.
Siddhartha ThakurDepartment of Population Health and Pathobiology, North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina, United States of America.

Funding

Enhancing the whole genome sequence(WGS)based surveillance of Salmonella, Listeria and Shiga Toxin producing Escherichia coli(STEC) isolated from food and environment at the national and global levelU18FD006194 · FDA · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI CRAY, PAULA, THAKUR, SIDDHARTHA · 2017 to 2018
$330k
FDA HHS U18 FD006194
6 · The paper itself

Abstract

International lineages, such as Salmonella Typhimurium sequence type (ST) 19, are most often associated with foodborne diseases and deaths in humans. In this study, we compared the whole-genome sequences of five S. Typhimurium strains belonging to ST19 recovered from clinical human stool samples in North Carolina, United States. Overall, S. Typhimurium strains displayed multidrug-resistant profile, being resistance to critically and highly important antimicrobials including ampicillin, ticarcillin/clavulanic acid, streptomycin and sulfisoxazole, chloramphenicol, tetracycline, respectively. Interestingly, all S. Typhimurium strains carried class 1 integron (intl1) and we were able to describe two genomic regions surrounding blaCARB-2 gene, size 4,062 bp and 4,422 bp for S. Typhimurium strains (HS5344, HS5437, and HS5478) and (HS5302 and HS5368), respectively. Genomic analysis for antimicrobial resistome confirmed the presence of clinically important genes, including blaCARB-2, aac(6')-Iaa, aadA2b, sul1, tetG, floR, and biocide resistance genes (qacEΔ1). S. Typhimurium strains harbored IncFIB plasmid containing spvRABCD operon, as well as rck and pef virulence genes, which constitute an important apparatus for spreading the virulence plasmid. In addition, we identified several virulence genes, chromosomally located, while the phylogenetic analysis revealed clonal relatedness among these strains with S. enterica isolated from human and non-human sources obtained in European and Asian countries. Our results provide new insights into this unusual class 1 integron in virulent S. Typhimurium strains that harbors a pool of genes acting as potential hotspots for horizontal gene transfer providing readily adaptation to new surrounds, as well as being crucially required for virulence in vivo. Therefore, continuous genomic surveillance is an important tool for safeguarding human health.

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial Agentsbeta-LactamasesGenome, BacterialHumansIntegronsMicrobial Sensitivity TestsPhylogenyPlasmidsSalmonella InfectionsSalmonella typhimuriumUnited StatesVirulence FactorsWhole Genome SequencingAnti-Bacterial Agentsbeta-LactamasesVirulence Factors

Identifiers

PMID33125394
PMCPMC7598458

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.